Retatrutide (often called “Reta”) is an investigational peptide developed for weight loss, obesity, and metabolic health. It is known as a triple agonist because it targets three hormone receptors at the same time: GLP-1, GIP, and glucagon receptors. This combination is designed to help reduce appetite, improve blood sugar control, increase feelings of fullness, and boost the body’s calorie-burning ability.

Potential benefits being studied include:

• Significant weight loss
• Reduced appetite and food cravings
• Improved insulin sensitivity
• Better blood sugar regulation
• Increased fat oxidation and energy expenditure
• Possible improvements in metabolic health and fatty liver disease 

Cones in crystal form. 
For research purposes only.